The DOI matches its Crossref record, with a small difference in title or year; 59 of the 60 references it cites were found in a registry or an index.
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
Open accessAbstract
The Huntington's disease (HD) gene has been mapped in 4p16.3 but has eluded identification. We have used haplotype analysis of linkage disequilibrium to spotlight a small segment of 4p16.3 as the likely location of the defect. A new gene, IT15, isolated using cloned trapped exons from the target area contains a polymorphic trinucleotide repeat that is expanded and unstable on HD chromosomes. A (CAG)n repeat longer than the normal range was observed on HD chromosomes from all 75 disease families examined, comprising a variety of ethnic backgrounds and 4p16.3 haplotypes. The (CAG)n repeat appears to be located within the coding sequence of a predicted approximately 348 kd protein that is widely expressed but unrelated to any known gene. Thus, the HD mutation involves an unstable DNA segment, similar to those described in fragile X syndrome, spino-bulbar muscular atrophy, and myotonic dystrophy, acting in the context of a novel 4p16.3 gene to produce a dominant phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Huntington’s Disease arises from an expansion of cytosine-adenine-guanine (CAG) trinucleotide repeats in the HTT gene (formerly IT15) of chromosome 4p16.3, leading to the production of a dysfunctional huntingtin protein (polyQ-HTT) [161,162].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [162]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HD is usually confirmed diagnostically through the identification of 36 or more CAG repeats on the short arm of chromosome 4p16.3 in the Huntingtin gene [162].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [162]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HD etiology is entirely due to autosomal-dominant HTT mutations with abnormal CAG repeat expansion in exon 1, producing mutant huntingtin protein that aggregates and leads to neurodegeneration (379).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [379]
Experimental — accuracy not yet measuredIn the citing paper
“The cause of Huntington's disease, an autosomal dominant neurological disorder, is well established as an abnormal expansion of CAG triplet repeats in exon 1 of the ubiquitously expressed huntingtin ( HTT ) gene, resulting in an elongated polyglutamine (Q) tract in the mutant huntingtin protein (mHTT) (MacDonald et al. , 1993).”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as MacDonald et al., 1993
In the citing paper
“In Huntington disease, poly-glutamine-expanded mHTT aggregates and accumulates194”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [194]
In the citing paper
“Huntington’s disease (HD) is an inherited disorder caused by a CAG trinucleotide repeat expansion in HTT which leads to progressive motor and cognitive impairment due to the gradual loss of neurons within striatal and cortical brain regions [1].”
From miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement (2015) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453
Research works printed but not linked: 2
- Gusella, J. F., Varsanyi-Breiner, A., Kao, F. T.. Jones, C., Puck, T. T., Keys, C., Orkin, S., and Housman, D. E. (1979). Precise localiza- tion of the human @globin gene complex on chromosome 11. Proc. Natl. Acad. Sci. USA 76, 5239-5243.
- Lehrach, H., Drmanac, R.. Hoheisel, J., Larin, Z., Lennon, G., Nizetic, D., Monaco, A., Zehetner, G., and Poustka, A. (1990). Hybridisation fingerprinting in genome mapping and sequencing. In Genome Analy- sis: Genetic and Physical Mapping, Volume 1, K. E. Davies and S. M. Tighlman, eds. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press), pp. 39-81.
Cited by
Sorted by citations
Items 801–900 of 1,087
Therapeutic Advances for Huntington’s Disease
Kumar, A., Kumar, V., Singh, K., Kumar, S., Kim, Y.-S., Lee, Y.-M., & Kim, J.-J. (2020) · Brain Sciences · doi:10.3390/brainsci10010043 · Cited by 170
Wild-Type Huntingtin Plays a Role in Brain Development and Neuronal Survival
Reiner, A. J., Dragatsis, I., Zeitlin, S. O., & Goldowitz, D. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:3:259 · Cited by 176
Ribchester, R. R., Thomson, D., Wood, N. I., Hinks, T., Gillingwater, T. H., Wishart, T. M., Court, F. A., & Morton, A. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03783.x · Cited by 165
Akt is altered in an animal model of Huntington's disease and in patients
Colin, E., Régulier, E., Perrin, V., Dürr, A., Brice, A., Aebischer, P., Déglon, N., Humbert, S., & Saudou, F. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03985.x · Cited by 164
Past, present and future role of retinal imaging in neurodegenerative disease
Kashani, A. H., Asanad, S., Chan, J. W., Singer, M., Zhang, J., Sharifi, M., Khansari, M. M., Abdolahi, F., Shi, Y., Biffi, A., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100938 · Cited by 169
Laboratory Guidelines for Huntington Disease Genetic Testing
NANCE, M. A., Seltzer, W. K., Ashizawa, T., Bennett, R. L., McIntosh, N. M., Myers, R. H., Potter, N. T., & Shea, D. K. (1998) · The American Journal of Human Genetics · doi:10.1086/301846 · Cited by 165
Modelling neurodegenerative diseases in Drosophila: a fruitful approach?
Muqit, M. M. K., & Feany, M. Β. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn751 · Cited by 168
Oliveira, J. M. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06741.x · Cited by 163
Bizat, N., Hermel, J., Boyer, F., Jacquard, C., Créminon, C., Ouary, S., Escartin, C., Hantraye, P., Krajewski, S., & Brouillet, E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05020.2003 · Cited by 163
The effect of neurodegenerative diseases on the subventricular zone
Curtis, M. A., Faull, R. L. M., & Eriksson, P. S. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2216 · Cited by 165
Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease
Carnemolla, A., Fossale, E., Agostoni, E., Michelazzi, S., Calligaris, R., Maso, L. D., Sal, G. D., MacDonald, M. E., & Persichetti, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018325 · Cited by 164
Self-citationThe Emergence of Modern Neuroscience: Some Implications for Neurology and Psychiatry
Cowan, W. M., Harter, D. H., & Kandel, E. R. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.343 · Cited by 172
Bemelmans, A., Horellou, P., Pradier, L., Brunet, I., Colin, P., & Mallet, J. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016393 · Cited by 164
Mende-Mueller, L. M., Toneff, T., Hwang, S.-R., Chesselet, M.-F., & Hook, V. Y. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01830.2001 · Cited by 163
Selective Neuronal Degeneration in Huntington's Disease
Cowan, C. M., & Raymond, L. A. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75002-5 · Cited by 166
Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease
Kudo, T., Schroeder, A., Loh, D. H., Kuljis, D. A., Jordan, M. C., Roos, K. P., & Colwell, C. S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.011 · Cited by 163
Huntington's Disease: Update and Review of Neuropsychiatric Aspects
Mendez, M. F. (1994) · The International Journal of Psychiatry in Medicine · doi:10.2190/hu6w-3k7q-nael-xu6k · Cited by 163
Østergaard, M. E., Southwell, A. L., Kordasiewicz, H. B., Watt, A. T., Skotte, N. H., Doty, C. N., Vaid, K., Villanueva, E. B., Swayze, E. E., Bennett, C. F., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt725 · Cited by 164
Therapeutic approaches to Huntington disease: from the bench to the clinic
Caron, N. S., Dorsey, E. R., & Hayden, M. R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.133 · Cited by 168
Harper, P. S., Lim, C., & Craufurd, D. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.8.567 · Cited by 163
Davies, S. W., Beardsall, K., Turmaine, M., DiFiglia, M., D, N. A. M., & Bates, G. P. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08360-8 · Cited by 163
Interaction of Mitochondrial Calcium and ROS in Neurodegeneration
Baev, A. Y., Vinokurov, A. Y., Novikova, I. N., Dremin, V. V., Potapova, E. V., & Abramov, A. Y. (2022) · Cells · doi:10.3390/cells11040706 · Cited by 162
Mitochondrial structural and functional dynamics in Huntington's disease
Reddy, P. H., Mao, P., & Mańczak, M. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.04.001 · Cited by 164
Shaping the role of mitochondria in the pathogenesis of Huntington's disease
Costa, V., & Scorrano, L. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.65 · Cited by 162
Ferrante, R. J., Gutekunst, C., Persichetti, F., McNeil, S. M., Kowall, N. W., Gusella, J. F., MacDonald, M. E., Beal, M. F., & Hersch, S. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03052.1997 · Cited by 162
Self-citationMetman, L. V., Morris, M. J., Farmer, C., Gillespie, M., Mosby, K. J., Wuu, J., & Chase, T. N. (2002) · Neurology · doi:10.1212/wnl.59.5.694 · Cited by 162
Mohlke, K. L., Purkayastha, A. A., Westrick, R. J., Smith, P. L., Petryniak, B., Lowe, J. B., & Ginsburg, D. (1999) · Cell · doi:10.1016/s0092-8674(00)80964-2 · Cited by 161
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease
Djoussé, L., Knowlton, B., Hayden, M., Almqvist, E. W., Brinkman, R., Ross, C., Margolis, R., Rosenblatt, A., Durr, A., Dode, C., et al. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20190 · Cited by 135
Self-citationIdentification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
Agrawal, N., Pallos, J., Slepko, N., Apostol, B. L., Bodai, L., Chang, L.-W., Chiang, A., Thompson, L. M., & Marsh, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500055102 · Cited by 160
Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila
Chan, H. Y. E. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2895 · Cited by 165
Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats
Li, S. H. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.777 · Cited by 162
Lovett, S. T., Vermeer, P. D., Sutera, V. A., & Gluckman-Peskind, T. J. (1993) · Genetics · doi:10.1093/genetics/135.3.631 · Cited by 161
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Jehuda, R. B., Shemer, Y., & Binah, O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9811-3 · Cited by 171
Theranostic applications of nanoparticles in neurodegenerative disorders
Ramanathan, S., Archunan, G., Sivakumar, M., Tamil Selvan, S., Fred, A. L., Kumar, S., Gulyás, B., & Padmanabhan, P. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s149022 · Cited by 161
Statistical issues in the search for genes affecting quantitative traits in experimental populations
Doerge, R. W., Weir, B. S., & Zeng, Z.-B. (1997) · Statistical Science · doi:10.1214/ss/1030037909 · Cited by 159
Sapp, E., Ge, P., Aizawa, H., Bird, E. D., Penney, J. B., Young, A. B., Vonsattel, J., & DiFiglia, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00427-7 · Cited by 161
Kipps, C., Duggins, A., McCusker, E. A., & Calder, A. (2007) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2007.19.7.1206 · Cited by 171
Fujigasaki, H. (2001) · Brain · doi:10.1093/brain/124.10.1939 · Cited by 161
Role of naturally occurring osmolytes in protein folding and stability
Kumar, R. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.007 · Cited by 161
Zhang, S., Binari, R., Zhou, R., & Perrimon, N. (2010) · Genetics · doi:10.1534/genetics.109.112516 · Cited by 160
Savas, J. N., Makusky, A. J., Ottosen, S., Baillat, D., Then, F., Krainc, D., Shiekhattar, R., Markey, S. P., & Tanese, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800658105 · Cited by 163
López-Sendón, J. L., Caldentey, J. G., Cubillo, P. T., Romero, C. R., Ribas, G. G., Arias, M. A. A. A., de Yébenes, M. J. G., Tolón, R. M., Galve‐Roperh, I., Sagredo, O., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8145-9 · Cited by 162
Wigley, W. C., Stidham, R. D., Smith, N. M., Hunt, J. F., & Thomas, P. (2001) · Nature Biotechnology · doi:10.1038/84389 · Cited by 160
Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)
Matsuyama, Z. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1283 · Cited by 160
Benomar, A., Krols, L., Stévanin, G., Cancel‐Tassin, G., Leguern, É., David, G., Ouhabi, H., Martin, J., Dürr, A., Zaǐm, A., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-84 · Cited by 160
Ataxia-Telangiectasia: Closer to Unraveling the Mystery
Shiloh, Y. (1995) · European Journal of Human Genetics · doi:10.1159/000472285 · Cited by 159
Huntington's disease – neuropathology
Vonsattel, J. P., Keller, C. E., & Cortes, E. P. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00004-5 · Cited by 164
Bisogno, T., & Marzo, V. D. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361568 · Cited by 159
Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders
Verkhratsky, A., & Parpura, V. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.025 · Cited by 162
Goody, S. M. G., Baum, M. L., Paspalas, C. D., Fernandez, S. M., Carty, N., Kurup, P. K., & Lombroso, P. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003053 · Cited by 162
Altered Expression of the Long Noncoding RNA NEAT1 in Huntington’s Disease
Sunwoo, J., Lee, S., Im, W., Lee, M., Byun, J., Jung, K., Park, K., Jung, K., Lee, S. K., Chu, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9928-9 · Cited by 154
Ekman, F. K., Ojala, D. S., Adil, M. M., Zapana, P. A. L., Schaffer, D. V., & Gaj, T. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.009 · Cited by 165
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
Jiang, A., Handley, R. R., Lehnert, K., & Snell, R. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241613021 · Cited by 174
Genetics and molecular biology of Huntington's disease
Albin, R. L., & Tagle, D. A. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93943-r · Cited by 159
Abnormal gene product identified in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) brain
Yazawa, I., Nukina, N., Hashida, H., Goto, J., Yamada, M., & Kanazawa, I. (1995) · Nature Genetics · doi:10.1038/ng0595-99 · Cited by 158
Glia in the pathogenesis of neurodegenerative diseases
Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., & Sofroniew, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140107 · Cited by 141
Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding
Xiao, G., Fan, Q., Wang, X., & Zhou, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308535110 · Cited by 162
Keum, J. W., Shin, A., Gillis, T., Mysore, J. S., Elneel, K. A., Lucente, D. E., Hadzi, T. C., Holmans, P., Jones, L., Orth, M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.018 · Cited by 158
Self-citationRecent Advances on the Pathogenesis of Huntington's Disease
Petersén, Å., Mani, K., & Brundin, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7006 · Cited by 160
Tetrabenazine in the treatment of hyperkinetic movement disorders
Kenney, C., & Jankovic, J. J. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.1.7 · Cited by 158
Guyot, M., Hantraye, P., Dolan, R., Palfi, S., Mazière, M., & Brouillet, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00602-1 · Cited by 158
Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22
Rosso, S. M. (2001) · Brain · doi:10.1093/brain/124.10.1948 · Cited by 158
Crapser, J. D., Ochaba, J., Soni, N., Reidling, J. C., Thompson, L. M., & Green, K. N. (2020) · Brain · doi:10.1093/brain/awz363 · Cited by 157
Moffitt, H., McPhail, G., Woodman, B., Hobbs, C., & Bates, G. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008025 · Cited by 151
Franich, N. R., Fitzsimons, H. L., Fong, D. M., Klugmann, M., During, M. J., & Young, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.50 · Cited by 160
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease
Milnerwood, A. J., Cummings, D. M., Dallérac, G. M., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., Rezaie, P., & Murphy, K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl092 · Cited by 157
Daguenet, É., Dujardin, G., & Valcárcel, J. (2015) · EMBO Reports · doi:10.15252/embr.201541116 · Cited by 159
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease
Martínez‐Horta, S., Pérez‐Pérez, J., van Duijn, E., de Bobadilla, R. F., Carceller‐Sindreu, M., Pagonabarraga, J., Pascual‐Sedano, B., Campolongo, A., Ruiz‐Idiago, J., Sampedro, F., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.008 · Cited by 157
Longitudinal Evaluation of theHdh(CAG)150Knock-In Murine Model of Huntington's Disease
Heng, M. Y., Tallaksen‐Greene, S. J., Detloff, P. J., & Albin, R. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1830-07.2007 · Cited by 165
Association of the α-Adducin Locus With Essential Hypertension
Casari, G., Barlassina, C., Cusi, D., Zagato, L., Muirhead, R., Righetti, M., Nembri, P., Amar, K., Gatti, M., Macciardi, F. M., et al. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.320 · Cited by 156
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
García-Revilla, J., Boza-Serrano, A., Espinosa-Oliva, A. M., Soto, M. S., Deierborg, T., Ruiz, R., de Pablos, R. M., Burguillos, M. A., & Venero, J. L. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05058-3 · Cited by 156
Assessment of the nutrition status of patients with Huntington's disease
Contreras, A. T., Tarrats, R. M., Alonso, M. E., Boll, M., Ochoa, A., & Velásquez, L. (2004) · Nutrition · doi:10.1016/j.nut.2003.10.007 · Cited by 156
Agrawal, S., Fox, J. A., Thyagarajan, B., & Fox, J. H. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.002 · Cited by 155
de Almeida, L. P., Zala, D., Aebischer, P., & Déglon, N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0388 · Cited by 163
Kim, S., Jeitner, T. M., & Steinert, P. M. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00064-x · Cited by 156
The Role of the Immune System in Huntington’s Disease
Ellrichmann, G., Reick, C., Saft, C., & Linker, R. A. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/541259 · Cited by 155
Jin, X.-F., Wu, N., Wang, L., & Li, J. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9940-9 · Cited by 159
The current clinical management of Huntington's disease
Phillips, W., Shannon, K. M., & Barker, R. A. (2008) · Movement Disorders · doi:10.1002/mds.21971 · Cited by 158
Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry
Schilling, B., Gafni, J., Torcassi, C., Cong, X., Row, R. H., LaFevre-Bernt, M. A., Cusack, M. P., Ratovitski, T., Hirschhorn, R. R., Ross, C. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513507200 · Cited by 159
Tandem-genotypes: robust detection of tandem repeat expansions from long DNA reads
Mitsuhashi, S., Frith, M. C., Mizuguchi, T., Miyatake, S., Toyota, T., Adachi, H., Oma, Y., Kino, Y., Mitsuhashi, H., & Matsumoto, N. (2019) · Genome biology · doi:10.1186/s13059-019-1667-6 · Cited by 159
Molecular Genetics of Huntington's Disease
Gusella, J. F., MacDonald, M. E., Ambrose, C. M., & Duyao, M. P. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540110037003 · Cited by 155
Self-citationTrinucleotide repeat length and clinical progression in Huntington's disease
Brandt, J., Bylsma, F., Gross, R., Stine, O. C., Ranen, N. G., & Ross, C. A. (1996) · Neurology · doi:10.1212/wnl.46.2.527 · Cited by 155
Oldham, M. C., Langfelder, P., & Horvath, S. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-63 · Cited by 154
Cholesterol metabolism in Huntington disease
Karasinska, J. M., & Hayden, M. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.132 · Cited by 154
Politis, M., Lahiri, N., Niccolini, F., Su, P., Wu, K., Giannetti, P., Scahill, R. I., Turkheimer, F., Tabrizi, S. J., & Piccini, P. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.011 · Cited by 156
The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease
Buckley, N. J., Johnson, R., Zuccato, C., Bithell, A., & Cattaneo, E. F. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.003 · Cited by 158
Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
Voisine, C., Varma, H., Walker, N., Bates, E. A., Stockwell, B. R., & Hart, A. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000504 · Cited by 155
Neuropsychiatric Burden in Huntington’s Disease
Paoli, R., Botturi, A., Ciammola, A., Silani, V., Prunas, C., Lucchiari, C., Zugno, E., & Caletti, E. (2017) · Brain Sciences · doi:10.3390/brainsci7060067 · Cited by 158
Melatonin: A review of its potential functions and effects on neurological diseases
Günata, M., Parlakpınar, H., & Acet, A. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.025 · Cited by 158
Membrane trafficking in health and disease
Yarwood, R., Hellicar, J., Woodman, P. G., & Lowe, M. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.043448 · Cited by 161
Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations
Wanker, E. E. (2000) · Biological Chemistry · doi:10.1515/bc.2000.114 · Cited by 154
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 154
Cloning and structural characterization of the human endothelial nitric‐oxide‐synthase gene
Miyahara, K., Kawamoto, T., Sase, K., Yui, Y., Toda, K., Li‐Xia, Y. A. N. G., Hattori, R., Aoyama, T., Yamamoto, Y., Doi, Y., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19045.x · Cited by 154
Fine-Scale Genetic Mapping Based on Linkage Disequilibrium: Theory and Applications
Xiong, M., & Guo, S. (1997) · The American Journal of Human Genetics · doi:10.1086/515475 · Cited by 153
Lysosome biogenesis in health and disease
Bajaj, L., Lotfi, P., Pal, R., Ronza, A. D., Sharma, J., & Sardiello, M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14564 · Cited by 153
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
Tabrizi, S. J., Workman, J. M., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G. P., Cooper, J. A. D., & Schapira, A. H. V. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1 · Cited by 353
Mouse models of Huntington's disease and methodological considerations for therapeutic trials
Ferrante, R. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.04.001 · Cited by 157
Impaired GAPDH‐induced mitophagy contributes to the pathology of Huntington's disease
Hwang, S., Disatnik, M., & Mochly‐Rosen, D. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505256 · Cited by 153
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
Chang, K., Cheng, M., Tang, H.-Y., Huang, C.-Y., Wu, Y., & Chen, C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0845-3 · Cited by 152
Metadata
- Authors
- MACDONALD, M.
- Affiliations
- Harvard University (US)
- Corresponding author
- MACDONALD, M
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1993-03
- Volume
- 72
- Issue
- 6
- Pages
- 971-983
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2121642311
- Semantic Scholar
- 47661acc507387c5d4de447493481bb376f88728
- Cited by
- 8,366
- References
- 60
- Citations by year
- 2026: 181 · 2025: 272 · 2024: 303 · 2023: 271 · 2022: 293 · 2021: 361 · 2020: 310 · 2019: 275 · 2018: 341 · 2017: 287 · 2016: 329 · 2015: 290 · 2014: 323 · 2013: 328 · 2012: 313
- FWCI
- 77.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- W. M. Keck Foundation
- Dana Foundation
- Hereditary Disease Foundation
- Bristol-Myers Squibb
- Wellcome Trust
- National Institutes of Health (5r01ns025631-06)
- Medical Research Council
- National Institute of Neurological Disorders and Stroke (R01NS022031, NS25631, NS 16367, NS22031)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- Huntington's disease, trinucleotide repeat expansion, CAG repeat, IT15 gene, chromosome 4p16.3, haplotype analysis, linkage disequilibrium, repeat instability, fragile X syndrome, myotonic dystrophy, gene mapping
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 4, Cloning, Molecular, Exons, Genes, Humans, Huntington Disease, Molecular Sequence Data, Mutation, Oligodeoxyribonucleotides, Pedigree, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, RNA, Messenger, Restriction Mapping, Gene Expression, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
